Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bronchial Neoplasms × trametinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 66 Neoplasms 37 Carcinoma, Non-Small-Cell Lung 24 Colorectal Neoplasms 17 Neoplasm Metastasis 15 Multiple Myeloma 11 Glioma 11 Thyroid Neoplasms 9 Thyroid Carcinoma, Anaplastic 9 Pancreatic Neoplasms 9 Hematologic Neoplasms 8 Brain Neoplasms 8 Lung Neoplasms 6 Triple Negative Breast Neoplasms 5 Neurofibromatosis 1 5 Astrocytoma 5 Rectal Neoplasms 4 Lymphoma 4 Glioblastoma 4 Colonic Neoplasms 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Uveal Melanoma 3 Skin Neoplasms 3 Recurrence 3 Oligodendroglioma 3 Neurofibroma, Plexiform 3 Leukemia, Myeloid, Acute 3 Biliary Tract Neoplasms 3 Bile Duct Neoplasms 3

Interventions

Carboplatin 8 Pemetrexed 6 osimertinib 5 pembrolizumab 3 entinostat 3 durvalumab 3 Radiosurgery 3 Cisplatin 3 Bevacizumab 3 selpercatinib 2 Paclitaxel 2 Erlotinib Hydrochloride 2 trametinib 1 sotorasib 1 repotrectinib 1 pralsetinib 1 patritumab 1 nazartinib 1 napabucasin 1 icotinib 1 exemestane 1 cobimetinib 1 ceralasertib 1 cemiplimab 1 capmatinib 1 camrelizumab 1 atezolizumab 1 alectinib 1 aflutinib 1 Toll-Like Receptor 1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03516214 2024-02-15

EATON

University of Cologne

Phase 1 Completed

Bronchial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡